Patel, S. K., Velkoska, E., & Burrell, L. M. (2013). Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in? Clinical and experimental pharmacology & physiology, 40(8), 551-559. https://doi.org/10.1111/1440-1681.12069
Chicago Style (17th ed.) CitationPatel, Sheila K., Elena Velkoska, and Louise M. Burrell. "Emerging Markers in Cardiovascular Disease: Where Does Angiotensin-converting Enzyme 2 Fit in?" Clinical and Experimental Pharmacology & Physiology 40, no. 8 (2013): 551-559. https://doi.org/10.1111/1440-1681.12069.
MLA (9th ed.) CitationPatel, Sheila K., et al. "Emerging Markers in Cardiovascular Disease: Where Does Angiotensin-converting Enzyme 2 Fit in?" Clinical and Experimental Pharmacology & Physiology, vol. 40, no. 8, 2013, pp. 551-559, https://doi.org/10.1111/1440-1681.12069.